Mar 16, 2015
1:100
For every 100 shares held, investors received 1. The price per share adjusted from $0.02 to $2.20.
The split itself did not change the total investment value.
MEDITE CANCER DIAGNOSTICS INC (OTC:MDIT) operates in the Medical specialties industry.
MEDITE CANCER DIAGNOSTICS INC company overviewMEDITE CANCER DIAGNOSTICS INC's most recent stock split was on March 16, 2015. It was a 1-for-100 reverse split, so shareholders received 1 share for every 100 they held.
MEDITE CANCER DIAGNOSTICS INC (OTC:MDIT) has split its stock 4 times: a 103-for-100 split on May 1, 1973, a 2-for-1 split on January 14, 1983, a 1-for-10 reverse split on November 28, 2007, and a 1-for-100 reverse split on March 16, 2015.
MEDITE CANCER DIAGNOSTICS INC has split its stock 4 times. This history records 4 splits between May 1, 1973 and March 16, 2015.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In MEDITE CANCER DIAGNOSTICS INC's 1-for-100 reverse split on March 16, 2015, every 100 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
MEDITE CANCER DIAGNOSTICS INC has not announced a new split in our records. Its most recent split was on March 16, 2015, 11 years ago. Companies announce splits in advance, and any new OTC:MDIT split will appear on this page.